Todd N Smith
CIK 1523672 · Director, Pres & CEO · last filed 2026-08-10
Todd N Smith is a Director, Pres & CEO who has filed 16 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for LTGO, was dated Aug 10, 2026. Across all open-market trades the lifetime net is −$94.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HZNP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 355
NORTHBROOK, IL 60062
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LTGO | Director | — | $14.04 | — | $0 | 1 | 2026-08-10 |
| Assertio Holdings, Inc. (ASRT) Delisted | Director, Pres & CEO | 10,749 | $23.50 | $252.6K | $0 | 1 | 2020-05-22 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP & Chief Commercial Officer | 54,711 | $116.30 | $6.36M | -$94.8K | 8 | 2015-02-04 |
| IVERIC bio, Inc. (OPHT) Delisted | SVP & CCO | — | — | — | $0 | 2 | 2015-01-06 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-10 | LTGO | Grant (A) | — | $0 | EDGAR |
| 2020-05-22 | Assertio Holdings, Inc. (ASRT) Delisted | Grant (A) | +644,925 | $0 | EDGAR |
| 2020-05-21 | — | Disp (D) | −365,500 | $0 | |
| 2020-03-05 | — | Grant (A) | +165,500 | $0 | |
| 2020-01-02 | — | Grant (A) | — | $0 | |
| 2019-10-24 | — | Grant (A) | +200,000 | $0 | |
| 2015-02-04 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Exer (M) | +13,750 | $0 | EDGAR |
| 2015-01-06 | IVERIC bio, Inc. (OPHT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-10-07 | IVERIC bio, Inc. (OPHT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-09-22 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Grant (A) | +54,138 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.